Suraksha Diagnostic Stock Screener | Share Price & Fundamental Analysis
SURAKSHA
Healthcare Service Provider
Screen Suraksha Diagnostic share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹275.40
▼
-1.25 (-0.45%)
Share Price BSE
₹274.10
▼
-2.15 (-0.78%)
Market Cap
₹1,440.81 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
6.17
EPS (TTM)
₹5.97
Dividend Yield
-
Debt to Equity
0.46
52W High
₹371.55
52W Low
₹259.20
Operating Margin
29.00%
Profit Margin
10.61%
Revenue (TTM)
₹66.00
EBITDA
₹20.00
Net Income
₹7.00
Total Assets
₹334.00
Total Equity
₹210.00
Suraksha Diagnostic Share Price History - Stock Screener Chart
Screen SURAKSHA historical share price movements with interactive charts. Analyze price trends and patterns.
Suraksha Diagnostic Company Profile - Fundamental Screener
Screen Suraksha Diagnostic company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SURAKSHA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE877V01027
Suraksha Diagnostic Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SURAKSHA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 334 | 300 | 281 | 0 | 171 |
| Current Assets | 47 | 72 | 68 | 0 | 27 |
| Fixed Assets | 223 | 212 | 195 | 0 | 119 |
| Liabilities | |||||
| Total Liabilities | 334 | 300 | 281 | 0 | 171 |
| Current Liabilities | 81 | 82 | 87 | 0 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 210 | 179 | 156 | 0 | 126 |
| Share Capital | 10 | 9 | 9 | 0 | 9 |
| Reserves & Surplus | 201 | 171 | 147 | 0 | 118 |
Screen SURAKSHA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Jun | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 66 | 74 | 80 | 56 | 62 | 68 | 60 | 53 | 61 | 53 |
| Expenses | 46 | 49 | 55 | 37 | 40 | 44 | 41 | 37 | 39 | 37 |
| EBITDA | 20 | 25 | 25 | 20 | 22 | 25 | 19 | 16 | 21 | 16 |
| Operating Profit % | 29.00% | 33.00% | 31.00% | 34.00% | 34.00% | 35.00% | 31.00% | 28.00% | 35.00% | 30.00% |
| Depreciation | 9 | 10 | 10 | 8 | 9 | 9 | 9 | 8 | 8 | 8 |
| Interest | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
| Profit Before Tax | 9 | 13 | 12 | 9 | 11 | 14 | 8 | 5 | 11 | 6 |
| Tax | 2 | 3 | 3 | 3 | 3 | 4 | 2 | 1 | 3 | 2 |
| Net Profit | 7 | 9 | 9 | 6 | 8 | 10 | 6 | 4 | 8 | 5 |
| EPS | 1.42 | 1.80 | 1.73 | 1.22 | 1.49 | 1.94 | 1.18 | 1.17 | 2.44 | 0.87 |
Suraksha Diagnostic Cash Flow Screener - Liquidity Fundamentals
Screen SURAKSHA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 63 | 61 | 44 | 42 | 24 | 31 |
| Investing Activities | -40 | -35 | -21 | -44 | -28 | -20 |
| Financing Activities | -24 | -25 | -24 | 1 | 3 | -10 |
| Net Cash Flow | 0 | 0 | -1 | 0 | -1 | 1 |
Screen SURAKSHA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Jul | 2024-Nov | 2024-Dec |
|---|---|---|---|---|---|---|
| Promoter Holding | 48.78% | 48.88% | 48.98% | 72.41% | 61.06% | 48.78% |
| FII Holding | 14.46% | 13.95% | 13.72% | 0.00% | 0.00% | 15.39% |
| DII Holding | 22.05% | 22.37% | 21.98% | 0.00% | 0.00% | 20.44% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.52% | 13.08% | 12.96% | 0.00% | 0.00% | 14.08% |
| Other Holding | 1.19% | 1.71% | 2.36% | 27.59% | 38.94% | 1.31% |
| Shareholder Count | 87,275 | 79,670 | 75,304 | 10 | 10 | 10 |
Suraksha Diagnostic Dividend Screener - Share Yield Analysis
Screen SURAKSHA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Suraksha Diagnostic Index Membership - Market Screener Classification
Screen SURAKSHA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Suraksha Diagnostic Market Events Screener - Corporate Actions
Screen SURAKSHA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -7.42% | ||
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.50% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -4.71% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 3.91% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 11.34% |
| 2024-12-20 | 2024-12-20 | Quarterly Result Announcement | NA | -0.81% |
Suraksha Diagnostic Competitors Screener - Peer Comparison
Screen SURAKSHA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,700 | 46.83 | 2,555 | 11.28% | 492 | 51.43 |
| Vijaya Diagnostic Centre | 10,881 | 70.34 | 700 | 23.06% | 144 | 61.34 |
| Metropolis Healthcare | 10,019 | 61.96 | 1,346 | 10.64% | 146 | 53.04 |
| Thyrocare Technologies | 7,309 | 56.28 | 702 | 20.80% | 91 | 53.15 |
| Nephrocare Health Services | 4,760 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,379 | 28.37 | 743 | 16.70% | 78 | 46.09 |
| Suraksha Diagnostic | 1,441 | 45.66 | 256 | 15.11% | 31 | 45.86 |
| One Global Service Provider | 1,237 | 28.65 | 148 | 134.60% | 19 | 58.56 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 56.43 |
| Sastasundar Ventures | 1,004 | -103.51 | 1,171 | -18.47% | -134 | 60.55 |
Suraksha Diagnostic Company Announcements - News Screener
Screen SURAKSHA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-22 | Closure of Trading Window | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-10 | Financial Results Of The Company For The Quarter And Six Months Ended 30 September 2025 | View |
| 2025-11-10 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Monday 10 November 2025 | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-03 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-09 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-22 | Closure of Trading Window | View |
| 2025-09-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-09-08 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-05 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-04 | Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Clarification On AGM Resolution | View |
| 2025-08-21 | Weblink Letter To Shareholders As Per Regulation 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |